Thirty-one cfDNA samples positive for IDH1, KRAS, PIK3CA, NRAS, AKT, BRAF, and IDH2 mutations in tumor tissue were selected for ddPCR, MassARRAY and NGS comparison. This evidence concerns the gene AKT1 and neoplasm.